Product information
| Components | TB-500 5 mg; BPC-157 5 mg |
|---|---|
| Physical form | Lyophilised multi-component research material |
| Current-batch HPLC result | 99.53% reported across the two components |
| Certificate of Analysis | Available on request for the current tested batch |
| Research classification | Research Use Only |
For laboratory and analytical research only. Not a medicine, food supplement or cosmetic. Not for human or veterinary use. No therapeutic or diagnostic use is intended.
Research context
This is a defined multi-component reference material containing TB-500 and BPC-157 in the stated nominal ratio. Both compounds appear separately in published experimental literature. Their inclusion in one vial is a formulation description only; no recovery, healing, treatment, performance or synergistic outcome is claimed.
Analytical considerations
Verify the component ratio and current-batch documentation before use. A combined HPLC result does not establish sterility, endotoxin status, suitability for a biological system or an outcome in a living organism.
Laboratory handling
Store lyophilised material at -20°C, protected from light. Select solvent and preparation conditions from a validated method compatible with both components and the intended analytical workflow. Record the calculated stock concentration of each component separately.
Documentation
Contact VeridianLabs for the current-batch COA and confirm that its batch identifier matches the supplied vial before relying on the reported result.
Reviews
There are no reviews yet.